Biotage AB and Shanghai Chempartner Co., Ltd. sign multi-instrument deal
Shanghai Chempartner Co., Ltd., one of China’s leading Contract Research Organizations (CRO), has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months. This is Biotages’s largest single order in China at a value of SEK 10m.
Biotage drug discovery instruments and consumables are widely used by medicinal chemists at the world’s leading pharmaceutical companies, and academic research laboratories. Many multinational pharmaceutical firms, with a long history of using Biotage equipment, have either built new research facilities in China or are outsourcing projects to Chinese CROs.
Chempartner provides contract research services to leading multinational pharmaceutical firms for rapid and cost effective production of compound libraries, novel intermediates, and lead optimization. Located in Shanghai Zhangjiang Hi-tech Park, Chempartner operates in four 210,000 sq. ft. state-of-the-art laboratory facilities with over 650 synthetic workstations.
Chempartner’s CEO, Michael Hui, says “We have expanded our operations over the last 4 years to accommodate the rapidly growing trend toward out-sourcing key elements of the drug discovery process. We need the most advanced tools available to create complex new molecules quickly and at high quality. Biotage provides a complete suite of automated tools that improve our workflow and allow our chemists to meet the high-standards of our clients; their instrument performance and proven reliability along with their strong commitment to our success were the key elements of our decision.”
“China is the fastest growing market for pharmaceutical contract research. Biotage has been successful in China and this commitment from Chempartner is a strong confirmation of our strategy and focus on drug discovery tools. We will continue to expand our relationships in China and work closely with Chempartner to ensure their success as they implement our equipment and consumables into their research programs." says Torben Jörgensen President and CEO of Biotage AB.